midazolam + ketamine + propofol

The midazolam + ketamine + propofol combination is a multi-drug sedative regimen used primarily for procedural sedation and analgesia, especially in settings such as colonoscopy and other interventional procedures. Each component contributes distinct pharmacological effects: - **Midazolam** is a benzodiazepine that acts as a positive allosteric modulator of the GABA-A receptor, providing anxiolysis, amnesia, and mild sedation. - **Ketamine** is an NMDA receptor antagonist with dissociative anesthetic properties; it provides analgesia and preserves airway reflexes while stimulating the cardiovascular system. - **Propofol** is a short-acting intravenous anesthetic that potentiates GABA-A receptor activity, resulting in hypnosis and deep sedation but can cause hypotension and respiratory depression. When combined, these agents allow for lower individual doses to achieve effective sedation with improved hemodynamic stability and reduced side effects compared to higher doses of single agents. The combination leverages the synergistic actions of each drug—midazolam’s anxiolysis/amnesia, ketamine’s analgesia/cardiovascular support, and propofol’s rapid-onset hypnosis—to provide safe procedural sedation with high patient satisfaction[1][6]. This regimen has been shown to be effective under both anesthetist supervision or trained nurse administration using patient-controlled devices[1].

Other names

midazolam-ketamine-propofol combination